Systems and methods for delivering vagal nerve stimulation
According to various method embodiments, a person is indicated for a therapy to treat a cardiovascular disease, and the therapy is delivered to the person to treat the cardiovascular disease. Delivering the therapy includes delivering a vagal stimulation therapy (VST) to a vagus nerve of the person at a therapeutically-effective intensity for the cardiovascular disease that is below an upper boundary at which upper boundary the VST would lower an intrinsic heart rate during the VST.
1. A method for titrating an intensity of an open loop vagal stimulation therapy (VST) to a therapeutically-effective dose for a cardiovascular disease, wherein the VST includes vagal stimulation (VS) delivered to a vagus nerve using an implantable medical device, the method comprising:
setting the intensity of the open loop VST after implantation of the device, wherein setting the intensity includes setting the intensity to avoid significant bradycardia; and
performing one or more follow-up therapy titration procedures, wherein performing the one or more follow-up therapy titration procedures includes adjusting the intensity of the open loop VST to provide the therapeutically-effective dose for the cardiovascular disease without causing VS-induced slowing of heart rate during VS.
2. The method of claim 1 , wherein setting the intensity of the open loop VST includes verifying capture using observed heart rate reduction, and setting the intensity below a threshold intensity that causes the observed heart rate reduction.
3. The method of claim 1 , wherein adjusting the intensity to avoid significant bradycardia includes allowing heart rate to slow during VST to 95% of heart rate without VST.
4. The method of claim 1 , wherein adjusting the intensity includes adjusting a VS ON duration for the VST.
5. The method of claim 1 , wherein adjusting the intensity includes adjusting a VS ON/VS OFF duty cycle for the VST.
6. The method of claim 1 , wherein adjusting the intensity includes adjusting an amplitude of the VS.
7. The method of claim 1 , wherein adjusting the intensity includes adjusting a frequency of the VS.
8. The method of claim 1 , wherein adjusting the intensity includes adjusting a pulse width of the VS.
9. The method of claim 1 , wherein adjusting the intensity includes reprogramming the implantable medical device using an external device to adjust the intensity.
10. The method of claim 9 , further comprising using the external device to indicate patient discomfort, and to adjust the intensity based on the patient discomfort.
11. The method of claim 1 , wherein the implantable device includes a timer and a programmed schedule, and wherein performing one or more follow-up procedures includes using the timer and the programmed schedule to adjust the intensity of the VST.
12. A method for providing a heart failure therapy, comprising:
delivering an open loop vagal stimulation therapy (VST), wherein the VST includes vagal stimulation (VS) delivered to a vagus nerve using an implantable medical device, and wherein delivering the VST includes setting the intensity to avoid significant bradycardia; and
titrating the intensity of the VST, using an external system to adjust programming of the implantable medical device, to a target intensity that is therapeutically effective to treat heart failure, wherein titrating the intensity includes performing one or more follow-up therapy titration procedures for adjusting the intensity to the target intensity without causing VS-induced slowing of heart rate during VS.
13. The method of claim 12 , further comprising using the external system to indicate patient discomfort, and to adjust the intensity based on the patient discomfort.
14. The method of claim 12 , further comprising using the external system to indicate VS-induced laryngeal vibration, and to adjust the intensity based on the VS-induced laryngeal vibration.
15. The method of claim 14 , wherein using the external system to adjust the intensity based on the VS-induced laryngeal vibration includes using an intensity threshold for the VST that induces laryngeal vibration as a lower boundary for the intensity.
16. The method of claim 12 , wherein delivering VST includes delivering VS using an implanted electrode operably positioned to stimulate the vagus nerve.
17. The method of claim 12 , wherein delivering VST includes using a nerve cuff to deliver VS to the vagus nerve.
18. The method of claim 12 , wherein delivering VST includes transvascularly stimulating the vagus nerve using an electrode in a blood vessel.
19. The method of claim 12 , wherein setting the intensity to avoid significant bradycardia includes verifying vagus nerve capture using an observed heart rate reduction, and changing the intensity to the intensity to avoid significant bradycardia.
20. The method of claim 12 , wherein performing one or more follow-up therapy titration procedures for adjusting the intensity to the target intensity without causing VS-induced slowing of heart rate during VS includes using the external system to monitor heart rate during times without VS and during times with VS to confirm that the VS does not induce slowing of heart rate during VS.
21. The method of claim 12 , wherein the implantable device includes a timer and a programmed schedule, the method further comprising using the timer and the programmed schedule in the implantable medical device to adjust the intensity of the VST to the target intensity.
22. A method for titrating an intensity of an open loop vagal stimulation therapy (VST) to a therapeutically-effective dose for a cardiovascular disease, wherein the VST includes vagal stimulation (VS) delivered to a vagus nerve using an implantable medical device and wherein the intensity of the open loop VS is initially set after implantation of the device to avoid significant bradycardia, the method comprising:
performing one or more follow-up therapy titration procedures, wherein performing the one or more follow-up therapy titration procedures includes adjusting the intensity of the open loop VST to a target intensity that is therapeutically effective for the cardiovascular disease without causing VS-induced slowing of heart rate during VS, wherein the implantable medical device includes a timer and a programmed schedule, and wherein performing one or more follow-up procedures includes using the timer and the programmed schedule to adjust the intensity of the VST to the target intensity.